No Data
No Data
12 Health Care Stocks Moving In Friday's Intraday Session
Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting
Express News | Plus Therapeutics Showcases New Interim Respect-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting
Plus Therapeutics Director Buys $6k Worth of Shares
Express News | Plus Therapeutics: On Sept 5 Got Letter From Nasdaq Notifying That Co Had Not Regained Compliance With Minimum Stockholders’ Equity Requirement
Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
No Data
No Data